Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Phenomenex to Host AACC Workshop on LC/MS/MS for Clinical Diagnostics

Published: Friday, May 10, 2013
Last Updated: Friday, May 10, 2013
Bookmark and Share
Two-day, hands-on program to be held May 15 and 16.

Phenomenex Inc. has announced that the company is collaborating with the Southern California Section of the American Association of Clinical Chemistry (AACC) in the development and presentation of a hands-on workshop on liquid chromatography with tandem mass spectrometry (LC/MS/MS).

The two-day training, which will count for 16 continuing education units, will teach clinical lab scientists how to develop and validate LC/MS/MS assays for diagnostic use.

A ratio of one instrument for every four users will ensure hands-on learning. LC/MS/MS is gaining rapid acceptance in the clinical lab due to its specificity and the amount of information it delivers, but the technique requires special training and skills.

The workshop, “Hands-On Development and Validation of LC/MS/MS Assays for Clinical Diagnostics,” was originally conceived by Dr. Paul Fu Sr. of the Harbor-UCLA Medical Center, longstanding education chair of the AACC’s Southern California Section.

“LC/MS/MS is a valuable tool in the clinical and healthcare settings,” commented Fu. “Phenomenex is the ideal partner to help us provide hands-on training in this technique because of their expertise in HPLC and their close relationship with AB SCIEX, a leading provider of mass spectrometry.”

Workshop instructors will be Seyed Sadjadi, clinical LC/MS/MS group leader at Phenomenex, who has prior experience at Quest Diagnostics and several mass spectrometry companies; Jenny Moshin, senior field application specialist for AB SCIEX; Brett Holmquist, Ph.D., associate director of the Labcorp’s Endocrine Sciences Laboratory (Esoterix Division); and David Truong, scientist within the PhenoLogix applications group at Phenomenex.

The workshop is partially underwritten by the Southern California Section of AACC, reducing the registration fee to $249 for members.

“Supporting educational activities for our members is very important to us and we want to make sure that the cost of the course is not a barrier for anyone that wants to attend,” says Eswari Gudipati, chair of the Southern California AACC Section.

The workshop will be held at Phenomenex headquarters in Torrance, CA. Participants may register online at: www.regonline.com/AACCmay.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
Heart Defect Prediction Technology Could Lead to Earlier, More Informed Treatment
Experimental method uses genetics-guided biomechanics, patient-specific stem cells.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
Big Data Can Save Lives
The sharing of genetic information from millions of cancer patients around the world could be key to revolutionising cancer prevention and care, according to a leading cancer expert from Queen's University Belfast.
Fast, Simple Test for Colitis
A minimally invasive screening for ulcerative colitis using emerging infrared technology could be a rapid and cost-effective method for detecting disease that eliminates the need for biopsies and intrusive testing of the human body.
Scans Reveal Babies of Mothers with Gestational Diabetes Have More Body Fat
Researchers at Imperial College London have found that the babies born to mothers with gestational diabetes have more body fat at two months of age compared to babies born to healthy mothers.
New Device Could Improve Cancer Detection
UBC researchers develop a microfluidic device to capture circulating tumor cells.
Plasma Biomarkers for Breast Cancer Diagnosis
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
Newborn Screening Test Developed For Rare, Deadly Neurological Disorder
Scientists have developed a new dried blood spot screening test for Niemann-Pick type C, with goal to speed diagnosis and treatment.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!